Binary Colloidal Crystals Promote Cardiac Differentiation of Human Pluripotent Stem Cells via Nuclear Accumulation of SETDB1

Abstract

Biophysical cues can facilitate the cardiac differentiation of human pluripotent stem cells (hPSCs), yet the mechanism is far from established. One of the binary colloidal crystals, composed of 5 μm Si and 400 nm poly(methyl methacrylate) particles named 5PM, has been applied as a substrate for hPSCs cultivation and cardiac differentiation. In this study, cell nucleus, cytoskeleton, and epigenetic states of human induced pluripotent stem cells on the 5PM were analyzed using atomic force microscopy, molecular biology assays, and the assay for transposase-accessible chromatin sequencing (ATAC-seq). Cells were more spherical with stiffer cell nuclei on the 5PM compared to the flat control. ATAC-seq revealed that chromatin accessibility decreased on the 5PM, caused by the increased entry of histone lysine methyltransferase SETDB1 into the cell nuclei and the amplified level of histone H3K9me3 modification. Reducing cytoskeleton tension using a ROCK inhibitor attenuated the nuclear accumulation of SETDB1 on the 5PM, indicating that the effect is cytoskeleton-dependent. In addition, the knockdown of SETDB1 reversed the promotive effects of the 5PM on cardiac differentiation, demonstrating that biophysical cue-induced cytoskeletal tension, cell nucleus deformation, and then SETDB1 accumulation are critical outside-in signal transformations in cardiac differentiation. Human embryonic stem cells showed similar results, indicating that the biophysical impact of the 5PM surfaces on cardiac differentiation could be universal. These findings contribute to our understanding of material-assistant hPSC differentiation, which benefits materiobiology and stem cell bioengineering.

A Transdermal Drug Delivery System Based on Nucleic Acid Nanomaterials for Skin Photodamage Treatment

“…tFNAs (1 µм) and LA solution with different concentrations (40, 80, 160, or 320 µм) were mixed by stirring for 6 hours to synthesize TLA with different tFNAs/LA ratios. [ 23b,41 ] tFNAs and TLA were stored at 4 °C. In subsequent experiments, the concentration of nucleic acid applied to cells or skin in tFNAs group and TLA group is the same.…”

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control

“…[292] Polymeric NPs containing formoterol recovered mitochondrial number and protein in the renal cortex and reduced tubular necrosis. [128] Recently, Duan et al demonstrated that a roper delay ironreplenishing therapy can significantly enhance the anti-AKI Active ingredient AKI Atv/PTP-TCeria NPs [ 55] -TPP 37.5 ± 2.62 −1.72 ± 0.433 Atorvastatin; Ceria NPs AKI IL-10 + EVs [ 207] EVs -134 -IL-10 AKI FNPs [ 128] --4 6 3 ± 40 -Formoterol AKI Fe 3 O 4 @NMN nanoprobes [ 293] NMN -3.4 26 NMN AKI SS-31 NPs [ 290] Hyaluronic acid targets CD44 SS-31 53 ± 0.17 -19.6 ± 0.7 SS-31 AKI MSC-Evs [ 227] --≈160 -miRNA200a-3p AKI nHA/PLBR [183] Hyaluronic acid -226.9 ± 4.5 -23.9 ± 0.2 Bilirubin AKI tFNA-Typ complex (TTC) [294] -16.93 ± 3.727 -9.74 ± 3.71 Typhaneoside AKI mSiO2@BA-AM/BAC@LTH NPs [ 295] Renal tubule-targeting peptide PEG-LTH -78.8 -13.3 BAPTA (Ca 2+ -selective chelator) AKI FNC/Cur [ 296] Ferritin -14 -17 ± 0.97 Curcumin AKI GA-NPs [ 297] --≈4.5 -Gambogic acid Chronic kidney disease COPT [211] --55.8 19.4 ± 2.01 Cobaltosic oxide Diabetic kidney disease Ad@Gel [ 292] --≈10 -Adropin…”

Structural DNA nanotechnology at the nexus of next-generation bio-applications: challenges and perspectives

“…It is designed to target mitochondria and renal tubules, providing increased antiapoptotic and antioxidative effects, as well as promoting mitochondria and kidney function restoration. 141 Functionalizing TDNs with unmethylated CpG motifs can induce immunostimulatory effects and produce pro-inammatory cytokines. 142,143 Aptamer-DOX conjugates have been designed to target prostate-specic membrane antigen (PSMA), which upon binding, leads to internalization and drug release inside the cell.…”